Summary
Patients with renal functional impairment are prone to develop hypertension and hyperlipidemia, and both abnormalities tend to occur already at an early stage of kidney disease. In 18 patients with mild renal disease (glomerular filtration rate 65±5 ml/min) and hypertension (mean blood pressure 126±4 mm Hg), the effect of six weeks of treatment with the loop-diuretic muzolimine on serum lipoproteins was assessed. Compared to placebo values, the diuretic significantly increased serum low-density lipoprotein cholesterol (LDL-C) and apoprotein B (+18 and 11%, respectively,P<0.005) in 13 men or postmenopausal women, but not in 5 premenopausal women. Serum high-density lipoprotein cholesterol (HDL-C), and total triglycerides or lipoprotein triglyceride fractions were not consistently changed in both subgroups. Thus, the ratio LDL-C/HDL-C was increased from 3.2±0.3 to 3.9±0.3 (P<0.05) in the men or postmenopausal women, while no such tendency occurred in the premenopausal women (4.1±0.6 to 3.7±0.6). Changes in serum LDL-C were not associated with hemoconcentration or alterations in carbohydrate metabolism and were not related to variations in serum potassium or blood pressure. Increased serum levels of the atherogenic LDL-C fraction during diuretic treatement in men or postmenopausal women with renal disease may represent a potentially undesirable effect, particularly since such patients may tend to have hyperlipidemia in the untreated state.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ames RP, Hill P (1976) Elevation of serum lipid levels during diuretic therapy of hypertension. Am J Med 61:748–757
Boehringer K, Meier A, Weidmann P, Schiffl H, Mordasini R, Riesen W (1981) Einfluß von Hydrochlorothiazid/Amilorid allein oder in Kombination mit a-Methyldopa auf die Serumlipoproteine. Schweiz Med Wochenschr 111:525–568
Boehringer K, Mordasini RC, Weidmann P, Schiffl H, Riesen W, Beretta-Piccoli C: Plasma lipids and lipoproteins in patients with mild impairment of renal function (Unpublished data)
Boehringer K, Weidmann P, Mordasini R, Schiffl H, Bachmann C (1982) Menopause-dependent plasma lipoprotein alterations in diuretic treated women. Ann Int Med 97
Girndt J, Assmann K, Seidel D, Scheler F (1982) Lipoproteine bei renaler Hypertonie. Med Welt 33:175–176
Glück Z, Baumgartner G, Weidmann P, Peheim E, Bachmann C, Mordasini R, Flammer J, Keusch G (1978) Increased ratio between serum β- and α-lipoproteins during diuretic therapy: an adverse effect? Clin Sci Mol Med 55:325s-328s
Glück Z, Weidmann P, Mordasini R, Bachmann C, Riesen W, Peheim E, Keusch G, Meier A (1980) Increased serum low-density-lipoprotein cholesterol in men treated short-term with the diuretic chlorthalidone. Metabolism 29:240–245
Goldmann AI, Steele BW, Schnaper HW, Fitz AE, Frohlich ED, Perry HM (1979) Serum lipoprotein levels during chlorthalidone therapy. J Am Med Assoc 244:1691–1695
Grimm RH Jr, Leon AS, Hunninghake DB, Lenz K, Hannan P, Blackburn H (1981) Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients. Ann Int Med 94:7–11
Hales CN, Randle PJ (1968) Immunoassay of insulin with insulin antibody precipitation. Biochem J 88:137–146
Helgeland A, Hjermann A, Holme I, Leren P (1978) Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension. The Oslo Study. Am J Med 64:34–38
Ibels LS, Stewart JH, Mahony JF, Neale FC, Sheil AGR (1977) Occlusive arterial disease in uremic and hemodialysis patients and renal transplant recipients. Q J Med 46:197–214
Joos C, Kewitz H, Reinhold-Kourniati D (1980) Effects of diuretics on plasma lipoproteins in healthy men. Eur J Clin Pharmacol 17:251–258
Kinne R, Kinne-Saffran E, Koenig B, Bayersdorffer E, Eveloff J (1981) The effect of muzolimine on chloride transporting organs. Nieren Hochdruckkrankh 10:79
Lipid Research Clinical Program (1974) Manual of laboratory operations, vol 1. U.S. Government Printing Office, Washington DC
Mancini G, Vaertmann JP, Carbonara AO, et al (1965) Immunochemic quantitation of antigen by single radial immunodiffusion. Immunochemistry 2:235–237
Meier A, Weidmann P, Mordasini R, Riesen W, Bachmann C (1982) Reversal or prevention of diuretic-induced alterations in serum lipoproteins with betablockers. Atherosclerosis 4:415–419
Mordasini R, Frey F, Flury W, Klose G, Greten H (1977) Selective deficiency of hepatic triglyceride lipase in uremic patients. N Engl J Med 297:1362–1366
Norbeck HE, Carlson LA (1981) The uremic dyslipoproteinemia: its characteristics and relations to clinical factors. Acta Med Scand 209:489–503
Schiffl H, Weidmann P, Mordasini R, Riesen W, Bachmann A (1982) Reversal of diuretic-induced increases in serum low-density lipoprotein cholesterol by the betablocker pindolol. Metabolism 31:411–415
Schiffl H, Weidmann P, Beretta-Piccoli C, Cottier C, Ziegler WH (1982) Antihypertensive mechanism of the diuretic muzolimine in mild renal failure. Roles of sodium and cardiovascular norepinephrine responsiveness. Eur J Clin Pharmacol (in press)
Schmidt P, Loew D, Dycka J, Kopsa H, Balcke P, Zazgornik J, Deutsch E (1978) Comparison of the pharmacologic effect of muzolimine and furosemide in patients with advanced chronic renal insufficiency. Eur J Clin Pharmacol 14:399–403
Weidmann P, Hirsch D, Beretta-Piccoli C, Reubi FC, Ziegler WH (1977) Interrelations among blood pressure, blood volume, plasma renin activity, and urinary catecholamines in benign essential hypertension. Am J Med 62:209–218
Weidmann P, Meier A, Mordasini R, Riesen W, Bachmann C, Peheim E (1981) Diuretic treatment and serum lipoproteins: Effects of tienilic acid and indapamide. Klin Wochenschr 59:343–346
Weidmann P, Schiffl H, Mordasini R, Meier A, Boehringer K, Riesen W (1982) Effects of diuretics alone or in combination with betablockers on serum lipoproteins. In: Noseda G (ed) Proceedings of the International Symposium on Lipoproteins and Coronary Atherosclerosis. Elsevier-North Holland, Amsterdam, pp 363–370
Author information
Authors and Affiliations
Additional information
This work was supported by the Swiss National Science Foundation
Rights and permissions
About this article
Cite this article
Schiffl, H., Weidmann, P., Mordasini, R. et al. Serum lipoproteins in patients with mild renal disease treated with the diuretic muzolimine. Klin Wochenschr 60, 1449–1453 (1982). https://doi.org/10.1007/BF01720992
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01720992